Company intelligence / Profile preview

PhytoPharmica

Green Bay, Wisconsin, United States

Ownership: Private
Development stage: Other

Overview

PhytoPharmica was a leading developer and distributor of science-based dietary supplements and natural medicines, primarily serving the healthcare practitioner market. The company specialized in botanical extracts and nutritional formulations backed by clinical research, often bridging the gap between traditional herbal medicine and modern pharmacology. PhytoPharmica eventually merged with Enzymatic Therapy to form Integrative Therapeutics, which was subsequently acquired by Schwabe North America (Nature's Way). Today, the PhytoPharmica brand legacy continues through the Integrative Therapeutics product line, focusing on high-quality, clinician-focused wellness solutions.

Therapeutic areas: ImmunologyNeurologyGastroenterology
Modalities: Small moleculeNatural productsDietary supplements
Industry: Food & Nutrition

Beyond the preview

Go deeper on PhytoPharmica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PhytoPharmica.

Explore the full profile